Brain-derived neurotrophic factor controls dopamine D3 receptor expression: Implications for neurodevelopmental psychiatric disorders

Neurotoxicity Research

Volumn 4, Issue 7-8, 2002, Pages 671-678

  Sokoloff, Pierre ^a   Guillin, Olivier ^a   Diaz, Jorge ^b   Carroll, Patrick ^c   Griffon, Nathalie ^a  

^a CENTRE PAUL BROCA   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

Behavioral sensitization; Drug addiction disease; Neurodevelopment; Schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE 3 RECEPTOR; LEVODOPA; NERVE GROWTH FACTOR; NEUROTRANSMITTER;

ADULTHOOD; ANIMAL TISSUE; BEHAVIOR; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DENERVATION; DEPRESSION; DEVELOPMENT; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; INNERVATION; MENTAL DISEASE; NERVE CELL; NERVE CELL DIFFERENTIATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RAT; REVIEW; SCHIZOPHRENIA; SENSITIZATION;

ANIMALIA;

EID: 0036853888     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1080/1029842021000045499     Document Type: Review

References (74)

1. Altar, C.A., Cai, N., Bliven, T., Juhasz, M., Conner, J.M., Acheson, A.L., Lindsay, R.M. and Wiegand, S.J. (1997) "Anterograde transport of brain-derived neurotrophic factor and its role in the brain", Nature 389, 856-860.
2. Altar, C.A. and Di Stefano, P.S. (1998) "Anterograde transport of neurotrophins in the nervous systems", Trends Neurosci. 21, 433-437.
3. Alvarez-Dolado, M., Ruiz, M., Del Rio, J.A., Alcantara, S., Burgaya, F., Sheldon, M., Nakajima, K., Bernal, J., Howell, B.W., Curran, T., Soriano, E. and Munoz, A. (1999) "Thyroid hormone regulates reelin and dab1 expression during brain development", J. Neurosci. 19, 6979-6993.
4. Bayer, S.A. and Altman, J. (1995) "Neurogenesis and neuronal migration", The Rat Nervous System (New York, Academic Press), pp 1041-1078.
5. Berendse, H.W., Galis-de-Graaf, Y. and Groenewegen, H.J. (1992) "Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat", J. Comp. Neurol. 316, 314-347.
6. 3 receptor expression as a mechanism of behavioral sensitization to levodopa", Proc. Natl. Acad. Sci. USA 94, 3363-3367.
7. Cabelli, R.J., Shelton, D.L., Segal, R.A. and Shatz, C.J. (1997) "Blockade of endogenous ligands of TrkB inhibits formation of ocular dominance columns", Neuron 19, 63-76.
8. 3 dopamine receptor gene expression in the rat forebrain: detection by reverse polymerase chain reaction", Neurosci. Lett. 155, 92-95.
9. Carlsson, A. (1988) "The current status of the dopamine hypothesis of schizophrenia", Neuropsychopharmacol. 1, 179-186.
10. 2 dopamine receptors", Mol. Pharmacol. 45, 51-60.
11. Cole, D.G., Kobierski, L.A., Konradi, C. and Hyman, S.E. (1994) "6-hydroxydopamine lesions of the rat substantia nigra upregulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons", Proc. Natl. Acad. Sci. USA 91, 9631-9635.
12. Conner, J. and Lauter, J.C. (1997) "Distribution of Brain-Derived Neurotrophic Factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport", J. Neurosci. 17, 2295-2313.
13. Das, K.P., Chao, S.L., White, L.D., Haines, W.T., Harry, G.J., Tilson, H.A. and Barone, Jr., S. (2001) "Differential patterns of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 mRNA and protein levels in developing regions of rat brain", Neuroscience 103, 739-761.
14. 3 receptors in the mouse brain: autoradiographic evidence for a transient cortical expression", Dev. Brain Res. 94,166-174.
15. 3 receptor", Neuroscience 65, 731-745.
16. 3 receptor mRNA in proliferative zones during embryonic development of the rat brain", J. Neurosci. 17, 4282-4292.
17. Dubertret, C., Gorwod, P., Ades, J., Feingold, J., Schwartz, J.-C. and Sokoloff, P. (1998) "A meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in caucasians", Am. J. Med. Genet. [Neuropsychiatr. Genet.] 81, 318-322.
18. Ernfors, P., Lee, K.-F. and Jaenisch, R. (1994) "Mice lacking brain-derived neurotrophic factor develop with sensory deficits", Nature 368, 147-150.
19. Fatemi, S.H., Earle, JA. and McMenomy, T. (2000) "Reduction of reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression", Mol. Psychiatr. 5, 654-663.
20. Figurov, A., Pozzo-Miller, L.D., Olafsson, P., Wang, T. and Lu, B. (1996) "Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus", Nature 381, 706-709.
21. Fishburn, C.S., David, C., Carmon, S. and Fuchs, S. (1994) "The effect of haloperidol on D2 dopamine receptor subtype mRNA levels in the brain", FEBS Lett. 339, 63-66.
22. 3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus", J. Neurosci. 16, 2020-2026.
23. Freeman, T.B., Spence, M.S., Boss, B.D., Spector, D.H., Strecker, R.E., Olanow, C.W. and Kordower, J.H. (1991) "Development of dopaminergic neurons in the human substantia nigra", Exp. Neurol. 113, 344-353.
24. 3 receptor expression and triggers behavioral sensitization", Nature 411, 86-89.
25. 3 receptors and use of antipsychotics in patients with schizophrenia", Arch. Gen. Psychiatr. 54, 225-232.
26. 3 receptor is selectively and transiently expressed in the developing whisker barrel cortex of the rat", J. Comp. Neurol. 420, 35-51.
27. Horger, B.A., Iyasere, C.A., Berhow, M.T., Messer, C.J., Nestler E.J. and Taylor, J.R. (1999) "Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor", J. Neurosci. 19, 4110-4122.
28. 1 dopamine receptor in rat brain reveals its axonal transport, pre- and post-synaptic localization, and prevalence in the basal ganglia, limbic system and thalamic reticular nucleus", Proc. Natl. Acad. Sci. USA 89, 11988-11992.
29. Impagnatiello, F., Guidotti, A.R., Pesold, C., Dwivedi, Y., Caruncho, H., Pisu, M.G., Uzuno, D.P., Smalheiser, N.R., Davis, J.M., Pandey, G.N., Pappas, G.D., Tueting, P., Sharma, R.P. and Costa, E. (1998) "A decrease of reelin expression as a putative vulnerability factor in schizophrenia", Proc. Natl. Acad. Sci. USA 95, 15718-15723.
30. Kafitz, K.W., Rose, C.R., Thoenen, H. and Konnerth, A. (1999) "Neurotrophin-evoked rapid excitation through TrkB receptors", Nature 401, 918-921.
31. Kerr, B.J., Bradbury, E.J., Bennett, D.L.H., Triverdi, P.M., Dassan, P., French, J., Shelton, D.B., McMahon, S.B. and Thompson, S.W.N. (1999) "Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord", J. Neurosci. 19, 5138-5148.
32. Korte, M., Carroll, P., Wolf, E., Brem, G., Thoenen, H. and Bonhoeffer, T. (1995) "Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor", Proc. Natl. Acad. Sci. USA 92, 8856-8860.
33. 3 receptor gene expression as a common effect of chronic antidepressant treatments", Mol. Psychiatr. 5, 378-388.
34. Lauder, J.M. (1993) "Neurotransmitters as growth regulatory signals: role of receptors and second messengers", Trends Neurosci. 16, 223-240.
35. Laufer, R. and Changeux, J.-P. (1989) "Activity-dependent regulation of gene expression in muscle and neuronal cells", Mol. Neurobiol. 3, 1-53.
36. 3H]-hydroxy-N,N di-n-propyl-2-aminotetralin", Proc. Natl. Acad. Sci. USA 89, 8155-8159.
37. 3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons", Proc. Natl. Acad. Sci. USA 92,1719-1723.
38. Linnarsson, S., Bjorklund, A. and Ernfors, P. (1997) "Learning deficit in BDNF mutant mice", Eur. J. Neurosci. 9, 2581-2587.
39. Miller, J.C. and Friedhoff, A.J. (1986) "Prenatal neuroleptic exposure alters postnatal striatal cholinergic activity in the rat", Dev. Neurosci. 8, 111-116.
40. Minichiello, L., Korte, M., Wolfer, D., Kühn, R., Unsicker, K., Cestari, V., Rossi-Arnaud, C., Lipp, H.-R, Bonhoeffer, T. and Klein, R. (1999) "Essential role for TrkB receptors in hippocampus-mediated learning", Neuron 24, 401-414.
41. 3 receptors: effects of MPTP and dopamine agonist replacement therapies", Eur. J. Neurosci. 10, 2565-2573.
42. Nibuya, M., Morinobu, S. and Duman, R.S. (1995) "Regulation of BDNF and TrkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments", J. Neurosci. 15, 7539-7547.
43. O'Brien, C.P., Childress, A.R., McMellan, A.T. and Ehrman, R.A. (1992) "A learning model of addiction", Res. Publ. Assoc. Res. Nerv. Ment. Dis. 70, 157-177.
44. Patterson, S.L., Abel, T., Deuel, T.A.S., Martin, K.C., Rose, J.C. and Kandel, E.R. (1996) "Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice", Neuron 16, 1137-1145.
45. Pennartz, C.M., Groenewegen, H.J. and Lopes da Silva, F.H. (1994) "The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data", Prog. Neurobiol. 42, 719-761.
46. 3 receptor agonist", Nature 400, 371-375.
47. 3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line", Eur. J. Pharmacol. [Mol. Pharmacol. Sect.] 268, 129-139.
48. Ringstedt, T., Linnarson, S., Wagner, J., Lendahl, U., Kokaia, Z., Arenas, E., Erfors, P. and Ibanez, C.F. (1998) "BDNF regulates reelin expression and Cajal-Retzius cell development in the cerebral cortex", Neuron 21, 305-315.
49. Rosengarten, H. and Fridhoff, A.J. (1979) "Enduring changes in dopamine receptor cells of pups from drug administration to pregnant and nursing rats", Science 203, 1133-1135.
50. 2 receptor is elevated in the striatum of Parkinson's disease", Mov. Disord. 13, 788-797.
51. 125I] iodosulpride", Neuroscience 28, 673-700.
52. Schuman, E. (1999) "Neurotrophin regulation of synaptic transmission", Curr. Opin. Neurobiol. 9, 105-109.
53. Schwartz, J.C., Costentin, J., Martres, M.P., Protais, P. and Baudry, M. (1978) "Modulation of receptor mechanisms in the CNS: hyper- and hyposensitivity to catecholamines", Neuropharmacology 17, 665-685.
54. 3 receptor in schizophrenia and anti-psychotic drug actions", Brain. Res. Rev. 31, 277-287.
55. Seroogy, K.B., Lundgren, K.H., Tran, T.M.D., Guthrie, K.M., Isackson, P.J. and Gall, C. (1994) "Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophin factor and neurotrophin-3 mRNAs", J. Comp. Neurol. 342, 321-334.
56. Shieh, P.B., Hu, S.C., Bobb, K., Timmusk, T. and Ghosh, A. (1998) "Identification of a signaling pathway involved in calcium regulation of BDNF expression", Neuron 20, 727-740.
57. Smith, M.A., Makino, S., Kvetnansky, R. and Post, R.M. (1995) "Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus", J. Neurosci. 15, 1768-1777.
58. 2 receptor", Eur. J. Pharmacol. Mol. Pharmacol. Sect. 225, 331-337.
59. 3 receptor and drug addiction", Neurotoxicity Res. 3, 433-441.
60. 3 dopamine receptors in the brain reward circuits of human cocaine fatalities", J. Neurosci. 16, 6100-6106.
61. 3 dopamine receptor mRNA is widely expressed in the human brain", Brain Res. 779, 58-74.
62. Takahashi, M., Shirakawa, O., Toyooka, K., Kitamura, N., Hashimoto, T., Maeda, K., Koizumi, S., Wakabayashi, K., Takahashi, H., Someya, T. and Nawa, H. (2000) "Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients", Mol. Psychiatr. 5, 293-300.
63. 2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism", Neuron 20, 709-726.
64. Tarazi, F.I., Florijn, W.J. and Creese, L (1997) "Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment", Neuroscience 78, 985-996.
65. Thoenen, H. (1995) "Neurotrophins and neuronal plasticity", Science 270, 593-598.
66. Vicario-Abejon, C., Collin, C., McKay, R.D.G. and Segal, M. (1998) "Neurotrophins induce formation of functional excitatory and inhibitory synapses between cultured hippocampal neurons", J. Neurosci. 18, 7256-7271.
67. von Bartheld, C.S., Byers, M.R., Williams, R. and Bothwell, M. (1996) "Anterograde transport of neurotrophins; and axodendritic transfer in the developing visual system", Nature 379, 830-833.
68. Voorn, P, Kalsbeek, A., Jorritsma-Byham, B. and Groenewegen, H.J. (1988) "The pre- and post-natal development of the dopaminergic cell group in the developmental mesencephalon and the dopaminergic innervation of the striatum of the rat", Neuroscience 25, 857-887.
69. Waddington, J. (1993) "Schizophrenia: developmental neuroscience and pathobiology", Lancet 341, 531-536.
70. Weinberger, D.R. (1987) "Implications of normal brain development for the pathogenesis of schizophrenia", Arch. Gen. Psychiatr. 44, 660-669.
71. Whitelaw, R.B., Markou, A., Robbins, T.W. and Everitt, B.J. (1996) "Excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second-order schedule of reinforcement", Psychopharmacology (Berl.) 127, 213-224.
72. 3 receptor gene and schizophrenia", Mol. Psychiatr. 3, 141-149.
73. Willner, P. and Sheel-Krüger, J. (1991) (Chichester, John Wiley).
74. Zahm, D.S. and Brog, J.S. (1992) "On the significance of subterritories in the "accumbens" part of the rat ventral striatum", Neuroscience 50, 751-767.